Mathilde Barrau
Saint-etienne-de-valoux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease.
Journal: United European gastroenterology journal
Published: December 30, 2025
Associations of advanced therapies in inflammatory bowel diseases.
Journal: Clinics and research in hepatology and gastroenterology
Published: October 27, 2025
Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study.
Journal: Journal of Crohn's & colitis
Published: August 25, 2025
Avolition Characterizes the Chronic Fatigue Experienced in Quiescent Inflammatory Bowel Disease.
Journal: Biomedicines
Published: November 28, 2024
Development and evaluation of two whole-blood flow cytometry protocols for monitoring patients treated with JAK inhibitors.
Journal: Immunotherapy advances
Published: September 19, 2024
New methods to unveil host-microbe interaction mechanisms along the microbiota-gut-brain-axis.
Journal: Gut microbes
Published: May 08, 2024
Risankizumab Concentration but not IL-22 Levels Are Associated With Clinical and Biochemical Remission in Patients With Crohn's Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 22, 2023
Higher Serum Infliximab Concentrations Following Subcutaneous Dosing are Associated with Deep Remission in Patients with Inflammatory Bowel Disease.
Journal: Journal of Crohn's & colitis
Published: November 07, 2023
What Should We Know about Drug Levels and Therapeutic Drug Monitoring during Pregnancy and Breastfeeding in Inflammatory Bowel Disease under Biologic Therapy?
Journal: Journal of clinical medicine
Published: October 01, 2023
Proton pump inhibitors and risk of severe COVID-19 in older people.
Journal: Age and ageing
Published: August 23, 2023
Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter Study.
Journal: Inflammatory bowel diseases
Published: June 08, 2023
Last Updated: 09/26/2026